The Globe and Mail reports in its Friday, Nov. 17, edition that Raymond James analyst Jeremy McCrea has reaffirmed his "outperform" recommendation for Crescent Point Energy. The Globe's David Leeder writes in the Eye On Equities column that Mr. McCrea gave his share target a 50-cent boost to $16.50. Analysts on average target the shares at $14.25. Mr. McCrea says Crescent Point's acquisition of the Duvernay in 2021, followed by Montney purchases in 2023, "look to significantly transform the future profitability of Crescent Point going forward. ... Crescent Point trades at a discounted valuation because of its past, but with top-quartile Montney assets (and inventory duration as well), the company is at a key turning point that is only starting to be recognized by investors. Despite some claims that Crescent Point 'overpaid,' that premise is viewed from a cashflow perspective. What Crescent Point really bought was multi-year, Tier 1 inventory, upon which we believe an incredible company will be built upon. Crescent Point is a much better company today and over the course of the next 20 years, we believe 2023 will be seen as that turning point, which likely will mark the low in valuation and share price."